Parsons Capital Management Inc Abbott Laboratories Transaction History

Parsons Capital Management Inc

  • $1.44 Billion
  • Q2 2024

A detailed history of Parsons Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Parsons Capital Management Inc holds 74,327 shares of ABT stock, worth $8.65 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
74,327
Previous 77,536 4.14%
Holding current value
$8.65 Million
Previous $8.81 Million 12.36%
% of portfolio
0.53%
Previous 0.61%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
SELL
$100.73 - $112.44 $323,242 - $360,819
-3,209 Reduced 4.14%
74,327 $7.72 Million
Q1 2024

Apr 22, 2024
SELL
$109.52 - $120.96 $267,447 - $295,384
-2,442 Reduced 3.05%
77,536 $8.81 Million
Q4 2023

Jan 22, 2024
SELL
$90.19 - $110.4 $174,066 - $213,072
-1,930 Reduced 2.36%
79,978 $8.8 Million
Q3 2023

Nov 06, 2023
BUY
$95.53 - $114.62 $35,823 - $42,982
375 Added 0.46%
81,908 $7.93 Million
Q2 2023

Aug 04, 2023
BUY
$100.78 - $112.29 $22,473 - $25,040
223 Added 0.27%
81,533 $8.89 Million
Q1 2023

Apr 17, 2023
SELL
$96.86 - $114.01 $331,261 - $389,914
-3,420 Reduced 4.04%
81,310 $8.23 Million
Q4 2022

Feb 13, 2023
BUY
$95.06 - $111.52 $20,057 - $23,530
211 Added 0.25%
84,730 $9.3 Million
Q3 2022

Oct 26, 2022
SELL
$96.76 - $112.03 $11,611 - $13,443
-120 Reduced 0.14%
84,519 $8.18 Million
Q2 2022

Jul 29, 2022
SELL
$102.07 - $123.37 $174,437 - $210,839
-1,709 Reduced 1.98%
84,639 $9.2 Million
Q1 2022

May 02, 2022
SELL
$114.02 - $139.04 $41,845 - $51,027
-367 Reduced 0.42%
86,348 $10.2 Million
Q4 2021

Feb 07, 2022
SELL
$115.53 - $141.46 $58,342 - $71,437
-505 Reduced 0.58%
86,715 $12.2 Million
Q3 2021

Nov 09, 2021
SELL
$116.66 - $129.06 $125,176 - $138,481
-1,073 Reduced 1.22%
87,220 $10.3 Million
Q2 2021

Aug 03, 2021
SELL
$105.79 - $124.53 $196,769 - $231,625
-1,860 Reduced 2.06%
88,293 $10.2 Million
Q1 2021

Apr 28, 2021
SELL
$108.84 - $128.23 $136,811 - $161,185
-1,257 Reduced 1.38%
90,153 $10.8 Million
Q4 2020

Feb 08, 2021
SELL
$105.0 - $114.42 $107,940 - $117,623
-1,028 Reduced 1.11%
91,410 $10 Million
Q3 2020

Oct 29, 2020
SELL
$91.64 - $111.29 $8,155 - $9,904
-89 Reduced 0.1%
92,438 $10.1 Million
Q2 2020

Aug 10, 2020
BUY
$76.57 - $98.0 $100,230 - $128,282
1,309 Added 1.44%
92,527 $8.46 Million
Q1 2020

May 05, 2020
SELL
$62.82 - $91.86 $684,738 - $1 Million
-10,900 Reduced 10.67%
91,218 $7.2 Million
Q4 2019

Feb 03, 2020
SELL
$78.51 - $87.4 $101,670 - $113,183
-1,295 Reduced 1.25%
102,118 $8.87 Million
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $85,850 - $93,088
-1,049 Reduced 1.0%
103,413 $8.65 Million
Q2 2019

Aug 01, 2019
SELL
$72.88 - $85.0 $269,801 - $314,670
-3,702 Reduced 3.42%
104,462 $8.79 Million
Q1 2019

Apr 26, 2019
SELL
$66.22 - $80.06 $85,887 - $103,837
-1,297 Reduced 1.18%
108,164 $8.65 Million
Q4 2018

Feb 01, 2019
SELL
$65.56 - $74.27 $85,621 - $96,996
-1,306 Reduced 1.18%
109,461 $7.92 Million
Q3 2018

Nov 13, 2018
SELL
$60.81 - $73.36 $104,289 - $125,812
-1,715 Reduced 1.52%
110,767 $8.13 Million
Q2 2018

Aug 09, 2018
SELL
$57.57 - $63.54 $20,955 - $23,128
-364 Reduced 0.32%
112,482 $0
Q1 2018

May 07, 2018
SELL
$56.27 - $63.62 $93,689 - $105,927
-1,665 Reduced 1.45%
112,846 $6.76 Million
Q4 2017

Feb 02, 2018
SELL
$53.68 - $57.47 $108,702 - $116,376
-2,025 Reduced 1.74%
114,511 $6.54 Million
Q3 2017

Oct 26, 2017
BUY
$48.06 - $53.64 $5.6 Million - $6.25 Million
116,536
116,536 $6.22 Million

Others Institutions Holding ABT

# of Institutions
3,133
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email